2013
Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention. Cancer Discov. 2013;3(1):44-51.
Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations. Diagn Cytopathol. 2013;41(1):35-40.
Single-trial classification of gait and point movement preparation from human EEG. Front Neurosci. 2013;7:84.
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023-31.
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2354-63.
The C terminus of the histone chaperone Asf1 cross-links to histone H3 in yeast and promotes interaction with histones H3 and H4. Mol Cell Biol. 2013;33(3):605-21.
Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial. J Invest Dermatol. 2013;133(6):1521-32.
Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol. 2013;41(9):757-61.
Expression of cyclin d1 and its association with disease characteristics in bladder cancer. Anticancer Res. 2013;33(12):5235-42.
Development and evaluation of a novel, semiautomated Clostridium difficile typing platform. J Clin Microbiol. 2013;51(2):621-4.